Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 67Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3LGM Pharma

02 2Aspen Pharmacare Holdings

03 12care4 ApS

04 1AAIPharma Services Corp.

05 2Actavis Inc

06 2Annora Pharma

07 2Aurobindo Pharma Limited

08 4Chartwell Pharmaceuticals llc

09 1Copley Scientific

10 2Epic Pharma. LLC.

11 2GSK

12 1Hanlim Pharmaceuticals Inc

13 2Impax Laboratories

14 2InvaGen Pharmaceuticals Inc

15 2Ipca Laboratories

16 2MALESCI SpA IST.FARMACOBIOL.

17 2MPP PHARMA

18 8Meda - Asker

19 3Meda AB

20 1Meda Pharmaceuticals Inc.

21 1Myungmoon Pharm. Co., LTD.

22 2Novitium Pharma LLC

23 2Oxford Pharm

24 2ScieGen Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Regulatory Info : RX

Registration Country : USA

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2019-08-30

Application Number : 203166

Regulatory Info : RX

Registration Country : USA

LGM Pharma CB

02

Nabumetone

Brand Name : Relifen 500

Dosage Form : TAB

Dosage Strength : 500mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Regulatory Info : RX

Registration Country : USA

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2019-08-30

Application Number : 203166

Regulatory Info : RX

Registration Country : USA

LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Regulatory Info : RX

Registration Country : USA

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2019-08-30

Application Number : 203166

Regulatory Info : RX

Registration Country : USA

LGM Pharma CB

05

Nabumetone

Brand Name : Relitone

Dosage Form : TAB

Dosage Strength : 500mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

06

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2002-02-25

Application Number : 75280

Regulatory Info : RX

Registration Country : USA

blank

07

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2002-02-25

Application Number : 75280

Regulatory Info : RX

Registration Country : USA

blank

08

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2003-01-24

Application Number : 76009

Regulatory Info : RX

Registration Country : USA

blank

09

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2003-01-24

Application Number : 76009

Regulatory Info : RX

Registration Country : USA

blank

10

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2000-06-06

Application Number : 75179

Regulatory Info : DISCN

Registration Country : USA

blank

11

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2002-02-25

Application Number : 75590

Regulatory Info : DISCN

Registration Country : USA

blank

12

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2002-02-25

Application Number : 75590

Regulatory Info : DISCN

Registration Country : USA

blank

13

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : RELAFEN

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1991-12-24

Application Number : 19583

Regulatory Info : DISCN

Registration Country : USA

blank

14

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : RELAFEN

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1991-12-24

Application Number : 19583

Regulatory Info : DISCN

Registration Country : USA

blank

15

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2000-05-26

Application Number : 75189

Regulatory Info : DISCN

Registration Country : USA

blank

16

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2001-09-24

Application Number : 75189

Regulatory Info : DISCN

Registration Country : USA

blank

17

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2008-03-07

Application Number : 78671

Regulatory Info : RX

Registration Country : USA

blank

18

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2008-03-07

Application Number : 78671

Regulatory Info : RX

Registration Country : USA

blank

19

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2008-09-24

Application Number : 78420

Regulatory Info : RX

Registration Country : USA

blank

20

Peptide Process CMC
Not Confirmed
arrow
arrow
Peptide Process CMC
Not Confirmed

NABUMETONE

Brand Name : NABUMETONE

Dosage Form : TABLET;ORAL

Dosage Strength : 750MG

Packaging :

Approval Date : 2008-09-24

Application Number : 78420

Regulatory Info : RX

Registration Country : USA

blank